Domov › Rakovina obličiek (renálny bunkový karcinóm) › Illinois

Klinické štúdie Rakovina obličiek (renálny bunkový karcinóm) v štáte Illinois

14 štúdií pre Rakovina obličiek (renálny bunkový karcinóm) hľadá účastníkov v zariadeniach v štáte Illinois.

Mestá v štáte Illinois

Oficiálny text štúdie (anglicky)

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NEO-811 Chicago Site, Zion

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07300241

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
a 54 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #26, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Rush MD Anderson Cancer Center, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
Carle at The Riverfront, Danville
a 12 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

City of Hope Chicago, City of Hope Cancer Center Chicago, Zion

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07594106

DESTINY-PANTUMOUR04

Research Site, Decatur

Prebieha náborObservačná štúdia

Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Centralia Oncology Clinic, Centralia
Northwestern University, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
a 25 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Memorial Hospital, Shiloh
Siteman Cancer Center - Shiloh, Shiloh
City Of Hope - Chicago, Zion

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07227415

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
Illinois CancerCare-Bloomington, Bloomington
a 53 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06661720

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Chicago
Xencor Investigative Site, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT05433142

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
Illinois CancerCare-Carthage, Carthage
a 13 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 6. 2026 · NCT07383441

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

University of Chicago, Chicago

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT06413680

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Saint Anthony's Health, Alton
Rush - Copley Medical Center, Aurora
Advocate Good Shepherd Hospital, Barrington
a 58 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2025 · NCT04510597

Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors

Loyola University Medical Center, Maywood

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 3. 2025 · NCT05728957

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.